[HTML][HTML] Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions

YB Liu, MK Chen - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …

Promises of microbiome-based therapies

JS Bajaj, SC Ng, B Schnabl - Journal of hepatology, 2022 - Elsevier
Humans harbour large quantities of microbes, including bacteria, fungi, viruses and
archaea, in the gut. Patients with liver disease exhibit changes in the intestinal microbiota …

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

R Moreau, M Tonon, A Krag, P Angeli, M Berenguer… - Journal of …, 2023 - Elsevier
Acute-on-chronic liver failure (ACLF), which was described relatively recently (2013), is a
severe form of acutely decompensated cirrhosis characterised by the existence of organ …

[HTML][HTML] Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections

A Zanetto, E Campello, C Bulato, S Gavasso… - JHEP Reports, 2022 - Elsevier
Background & Aims Bacterial infections in cirrhosis are associated with increased bleeding
risk. To assess the factors responsible for bleeding tendency in patients with bacterial …

[HTML][HTML] Early diagnosis and prevention of infections in cirrhosis

AV Kulkarni, M Premkumar, JP Arab… - Seminars in Liver …, 2022 - thieme-connect.com
Strategies to prevent infection and improve outcomes in patients with cirrhosis. HAV,
hepatitis A virus; HBV, hepatitis B virus; COVID-19, novel coronavirus disease 2019; NSBB …

Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment

Y Huang, X Guo, Y Wu, X Chen, L Feng, N Xie… - … and Targeted Therapy, 2024 - nature.com
Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

Faecal microbiota transplantation, paving the way to treat non-alcoholic fatty liver disease

M Del Barrio, L Lavín, Á Santos-Laso… - International Journal of …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic
liver disease (CLD). Currently, the only therapeutic recommendation available is a lifestyle …

[HTML][HTML] The shaping of gut immunity in cirrhosis

L Muñoz, E Caparrós, A Albillos, R Francés - Frontiers in Immunology, 2023 - frontiersin.org
Cirrhosis is the common end-stage of chronic liver diseases of different etiology. The altered
bile acids metabolism in the cirrhotic liver and the increase in the blood-brain barrier …

[HTML][HTML] Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure

J Clària, V Arroyo, R Moreau - JHEP Reports, 2023 - Elsevier
Acute-on-chronic liver failure (ACLF) is the most severe form of acutely decompensated
cirrhosis and is characterized by the presence of one or more organ failures, intense …

Roles for the mycobiome in liver disease

S Zeng, B Schnabl - Liver International, 2022 - Wiley Online Library
Liver disease, a major cause of global mortality, has been associated with dysbiosis of the
intestinal microbiota (bacteria, fungi, viruses, and other microbes). Studies have associated …